Corridor launches with $25m to fix health benefits for small businesses
Corridor launches with $25m to fix health benefits for small businesses

“For decades, small businesses have been sold the leftovers of the health insurance market,” said Nikhil Aggarwal, chief executive and co-founder of Corridor. His company launched its AI benefits brokerage on Monday with $25m. Its plan is to change tha…

Oura’s IPO seeks $2.2bn, and 73% of it goes to existing shareholders
Oura’s IPO seeks $2.2bn, and 73% of it goes to existing shareholders

Oura spent the first nine months of its financial year buying its own shares back from its investors. On Monday it started selling them to everybody else. The Finnish smart ring maker launched its initial public offering before the New York open. It is…

Novo will test Anthropic’s Claude Science to speed up drug discovery
Novo will test Anthropic’s Claude Science to speed up drug discovery

“Joining forces with Anthropic will supercharge our R&D organisation and help us on our mission to bring new, transformative health solutions to people living with chronic diseases,” said Mike Doustdar, president and chief executive of Novo. The Da…

ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports
ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports

ByteDance closed a $290M funding round for Anew Labs, its newly spun-off AI drug discovery unit, at a $1.5B valuation, Reuters reports, citing two sources familiar with the matter. Moreover, the company that owns TikTok will retain 56% of the business …

Tandem Health raises $100m to turn its AI scribe into clinic software
Tandem Health raises $100m to turn its AI scribe into clinic software

Stockholm-based Tandem Health has raised $100m in a Series B round led by the Scaleup Europe Fund, which EQT manages. The company announced the round on 14 September. Existing investors Kinnevik, Northzone, Amino Collective, and Visionaries also took p…

The data storage crisis has a biological fix. It starts by making less DNA, not more.
The data storage crisis has a biological fix. It starts by making less DNA, not more.

The math behind the data storage problem is brutal. The world creates more information every year than it can afford to keep. Most of it is cold. It is almost never read, yet it cannot be deleted, so it accumulates on tape and disk that degrade, draw p…

Health minister says mistrust of Palantir is pushing NHS patients to opt out of data sharing
Health minister says mistrust of Palantir is pushing NHS patients to opt out of data sharing

The UK minister responsible for health innovation has told MPs that public mistrust of Palantir is making patients less willing to hand their medical records to the NHS, and that the number of people formally opting out of data sharing has risen by rou…

Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial
Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial

Blood samples from a small lung-disease trial have been run through six independently built ageing clocks, and all six returned the same answer: the patients on the drug looked biologically younger than the patients on placebo. “More lifetimes than hum…

Ultrahuman raised $70m to turn its ring into a computer
Ultrahuman raised $70m to turn its ring into a computer

Ultrahuman has raised $70m, and the pitch it made to get the money is not a better sleep score. The Indian company wants its smart ring to stop being a tracker and start running software. TechCrunch’s Jagmeet Singh reported the round first, with an int…

Oura’s $924m loss is the price of buying back its own shares
Oura’s $924m loss is the price of buying back its own shares

Oura filed to go public on Nasdaq on 3 September, and the coverage split within hours. Reuters reported that the smart ring maker had recently turned profitable. The Wall Street Journal told its readers the same. Bloomberg’s Subrat Patnaik led on a los…